CDC42BPB anticorps (AA 1609-1711) (FITC)
Aperçu rapide pour CDC42BPB anticorps (AA 1609-1711) (FITC) (ABIN7169074)
Antigène
Voir toutes CDC42BPB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1609-1711
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Serine/threonine-protein kinase MRCK beta protein (1609-1711AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDC42BPB (CDC42 Binding Protein Kinase beta (DMPK-Like) (CDC42BPB))
-
Autre désignation
- CDC42BPB
-
Sujet
-
Background: Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.
Aliases: CDC42 binding protein kinase beta antibody, CDC42-binding protein kinase beta antibody, CDC42BPB antibody, DMPK like beta antibody, DMPK-like beta antibody, KIAA1124 antibody, MRCK beta antibody, MRCKB_HUMAN antibody, Myotonic dystrophy kinase related CDC42 binding kinase beta antibody, Myotonic dystrophy kinase-related CDC42-binding kinase beta antibody, Myotonic dystrophy protein kinase like beta antibody, Myotonic dystrophy protein kinase-like beta antibody, Serine/threonine protein kinase MRCK beta antibody, Serine/threonine-protein kinase MRCK beta antibody
-
UniProt
- Q9Y5S2
Antigène
-